This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Phytopharm Plc. Active years: 2001-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saffron Walden, GB (2001 - 2008)
- Godmanchester, GB (2010)
Company Filing History:
Years Active: 2001-2010
Title: The Innovations of Philip James Gunning
Introduction
Philip James Gunning is a notable inventor based in Godmanchester, GB. He has made significant contributions to the field of steroidal sapogenins, holding a total of 3 patents. His work focuses on innovative methods that enhance the preparation and application of these compounds.
Latest Patents
Gunning's latest patents include a method for the stereospecific reduction of sapogen-3-ones. This method allows for the preparation of steroidal sapogenins or their derivatives by reducing a 3-keto, 5β-H steroidal sapogenin using hindered organoborane or organo-aluminium hydride. Additionally, he has developed a method for preparing a 3β-hydroxy, 5β-H steroidal sapogenin or derivative through the use of a relatively highly hindered organoborane reagent. His inventions provide a convenient route to useful steroidal sapogenins such as sarsasapogenin, episarsasapogenin, smilagenin, and epismilagenin, which can be derived from readily available starting materials.
Career Highlights
Gunning is currently associated with Phytopharm Plc, where he continues to innovate in the field of pharmaceutical applications. His work has implications for the treatment of cognitive dysfunction and similar conditions, showcasing the potential therapeutic benefits of smilagenin.
Collaborations
Gunning has collaborated with notable colleagues, including Zongqin Xia and Ian Duncan Rubin, contributing to the advancement of research in his field.
Conclusion
Philip James Gunning's contributions to the field of steroidal sapogenins highlight his innovative spirit and dedication to advancing pharmaceutical science. His patents and ongoing work continue to pave the way for new treatments and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile